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Polymeric substrates are being identified that could permit translation of human 13 
pluripotent stem cells (hPSCs) from lab-based research to industrial-scale 14 
biomedicine. Well-defined materials are required to allow cell banking and to provide 15 
the raw material for reproducible differentiation into lineages for large-scale drug-16 
screening programs and clinical use. Yet more than 1 billion cells for each patient are 17 
needed to replace losses during heart attack, multiple sclerosis and diabetes. 18 
Producing this number of cells is challenging, and a rethink of the current 19 
predominant cell-derived substrates is needed to provide technology that can be 20 
scaled to meet the needs of millions of patients a year. In this review, we consider the 21 
role of materials discovery, an emerging area of materials chemistry that is in large 22 
part driven by the challenges posed by biologists to materials scientists1–4. 23 
 24 
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The term human pluripotent stem cells (hPSCs) describes both human embryonic 1 
stem cells (hESCs), typically derived from the inner cell mass of pre-implantation 2 
embryos5, and human induced pluripotent stem cells (hiPSCs), derived by epigenetic 3 
reprogramming of somatic cells with stem cell-associated factors6. Because hPSCs 4 
can self-renew in culture for months if not years, and can be induced to differentiate 5 
into all three germ layers, they provide immense potential for regenerative medicine 6 
and drug development, as well as for new in vitro models of genetic disease7. 7 
However, for biomedical applications to be realized, defined culture conditions need 8 
to be established in order to eliminate batch variability and xenogenic contaminants. 9 
Furthermore, scalable culture systems are required8-9. For adherent culture systems, 10 
scalability is often achieved by increasing the surface area of a candidate growth 11 
substrate in T-75 flasks (75 cm2 growth area) without compromising biological 12 
performance as measured by pluripotency markers. 13 
In comparison with a cell derived proteinaceous mixture such as Matrigel10, polymers 14 
are not prone to batch-to-batch biological variations and they are readily amenable to 15 
large-scale manufacture; for example, injection moulding is currently used to form 16 
tens of millions of tissue-culture vessels per year. Consequently, there are significant 17 
efforts to identify synthetic substrates on which to support pluripotent stem cell 18 
expansion. The ultimate aim would be to have an inexpensive polymer that can be 19 
used off-the-shelf without pre- adsorption of proteins or immobilization of other 20 
biomolecules such as peptides. Ideally, a fully synthetic growth substrate would be 21 
amenable to automated robotic cell culture, paving the way for stem cell factories that 22 
could manufacture billions of hPSCs suitable for clinical use. 23 
This review describes the development of growth substrates for hPSC culture, from 24 
cell extracts to polymeric materials, and assesses the cost and scalability issues 25 
 3 
 
associated with the most recent advances in hPSC culture, with a particular focus on 1 
materials discovery. 2 
 3 
 4 
Feeder layers to support hPSC growth 5 
 6 
Table 1 summarizes progress made over the last 15 years towards more precisely 7 
defined culture systems for hPSCs. Initial reports of hPSC culture employed feeder 8 
layers of mouse embryonic fibroblasts (MEFs) to support the self-renewal of hPSCs. 9 
Feeder layers provide a source of extracellular matrix (ECM) proteins and growth 10 
factors — such as vitronectin, transforming growth factor  (TGF-) and Laminin-11 
511 — that aid hPSC proliferation and self-renewal. In 1998, a MEF feeder layer was 12 
employed to support hPSC growth in a medium of 80% Dulbecco’s modified Eagle’s 13 
medium (DMEM), supplemented with 20% fetal bovine serum (FBS), 1mM 14 
glutamine, 0.1mM -mercaptoethanol and 1% nonessential amino acids (NEAA)5. 15 
However, the use of non-human (xeno) feeder layers and animal-derived serum such 16 
as FBS represent a potential source of pathogens, such as endogenous retroviruses and 17 
xeno epitopes (such as nonhuman sialic acid and N-glycolneuraminic acid (Neu5Gc), 18 
a monosaccharide)11. Factors such as Neu5Gc can induce an immune response upon 19 
transplantation of hPSCs cultured using xenogenic methods, and limit their use to in 20 
vitro applications. 21 
 22 
 23 
 24 
 25 
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Table 1. Milestones in hPSC culture and growth substrate materials discovery. 1 
Year Description 2 
1998 First hESCs harvested from blastocyst and cultured on mouse-derived feeder 3 
cells5 4 
 Combinatorial polymer library used to screen for structure-property 5 
relationships69 6 
2001 First report of hESC culture on Matrigel using feeder-free conditions11 7 
2004 First report of hESC culture on Fibronectin matrix using feeder-free and 8 
serum-free conditions25 9 
 First polymer microarray used to screen for hESC growth and differentiation52 10 
 Subtle changes in polymer chemistry shown to influence protein adsorption 11 
behaviour62 12 
2006 First report of defined hESC culture in feeder- and xeno-free conditions using 13 
TeSR1 medium17 14 
2007 ROCK inhibitor employed to reduce cell apoptosis during cell passaging26 15 
 High-throughput surface characterization of a polymer microarray72 16 
2008 Vitronectin and isoforms of Lamini identified from extracellular matrix to 17 
support hESC growth41 18 
 Surface wettability of a combinatorial polymer microarray modelled using 19 
multivariate analysis73 20 
2010 Long-term self-renewal on Laminin-511 surfaces in defined O3 medium and 21 
xeno-free H3 medium43 22 
 Synthetic polymer surface employed in StemPro medium47 23 
 Surface chemistry of polymer surfaces shown to influence hESC growth53 24 
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2011 Long-term hESC self-renewal on polymer surface achieved in mTeSR1 1 
medium48 2 
2012 Human embryoid body cell adhesion to a combinatorial polymer library 3 
modelled using molecular descriptors70 4 
 Long-term self-renewal of hPSCs on Laminin E8 surfaces in TeSR2 medium42 5 
2013 Long-term hESC self-renewal and thermally-triggered passaging achieved 6 
using thermoresponsive hydrogel in mTeSR1 medium55 7 
 8 
Feeder-free hPSC culture  9 
 10 
To produce hPSCs that are safer and more useful in clinical applications, feeder-free 11 
culture systems have been developed. The need to replace feeder layers with 12 
alternative growth substrates has driven a huge research effort in the discovery of 13 
biological substrates that support the long-term self-renewal of hPSCs. Initial work on 14 
feeder-free systems in 2001 employed animal-derived growth substrates (such as 15 
Matrigel) in combination with a MEF-conditioned medium (MEF-CM)10. Matrigel is 16 
harvested from Engelbreth-Holm-Swarm (EHS) mouse sarcoma cells, and consists of 17 
a complex mixture of various extracellular matrix (ECM) proteins, proteoglycans and 18 
growth factors12. Matrigel is currently very widely used, but is unfortunately prone to 19 
batch-to-batch variability in the same way as all biologically based culture systems 20 
such as MEF–CM. This complexity within a culture system make understanding and 21 
controlling the cell/material interface more difficult, which are prerequisites to 22 
developing a scalable and reproducible hPSC culture system. Furthermore, batches of 23 
Matrigel have been contaminated with lactate dehydrogenase-elevating virus (LDV). 24 
This highlights safety concerns with xenogenic media components, although this 25 
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particular pathogenic risk can be avoided with the use of Geltrex, an undefined LDV-1 
free growth substrate (Table 2)11, 13-24. Subsequently, Matrigel was offered as an 2 
LDV-free product.  3 
Concerns over xenobiotic contamination have prompted the development and use of 4 
serum-free media in combination with growth substrates containing recombinant 5 
proteins25. In 2004, the self-renewal of I3, I6 and H9 hPSC lines on a fibronectin 6 
matrix using a serum replacement consisting of various growth factors known to play 7 
a role in maintenance of pluripotency was demonstrated25. Basic fibroblast growth 8 
factor (bFGF), transforming growth factor 1 (TGF1) and leukaemia inhibitory 9 
factor (LIF) were tested in different mixtures. A combination of TGF1 and bFGF 10 
with and without LIF was able to maintain pluripotency and retain normal hPSC 11 
features on a human fibronectin growth substrate. However, growth rates and cloning 12 
efficiencies of all combinations were inferior to MEF controls.  13 
 14 
Table 2. Commercialized growth substrates and culture media for hPSC culture. 15 
Component Product             Defined Synthetic Xeno-free Origin              Form 16 
Growth  MatrigelTM, BD Biosciences11    ×           ×         ×      Cell extract             Gel 17 
substrate GeltrexTM, Invitrogen      ×           ×         ×      Cell extract             Gel 18 
SynthemaxTM, Corning13                             Peptide-polymer     Powder/Coated 19 
               conjugate                cultureware  20 
  
StemAdhereTM,                               Recombinant protein   Liquid 21 
  Primorigen Biosciences14            (E-Cadherin)  22 
NunclonVitaTM,                               Plasma treated    Cultureware 23 
Liquid Thermo Scientific15         polystyrene 24 
  CellStartTM, Invitrogen16                                                      Humanized protein      Liquid 25 
             mixture 26 
 27 
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            Defined    Feeder-free    Xeno-free    Serum-free 1 
Culture HEScGRO, Millipore              ×              2 
Medium mTeSR1TM, STEMCELL Technologies17                            ×          3 
  TeSR2TM, STEMCELL Technologies17                         4 
  
StemProTM, Invitrogen18               ×          5 
  NutriStemTM, STEMGENT19                          6 
  
E8TM, GIBCO20                          7 
  XVIVOTM 10, Lonza21-22                         8 
  RegES23              ×             9 
  hESF924                           10 
   11 
A major milestone in hPSC culture was the development of a defined culture medium 12 
called TeSR1, and published in 2006 (ref. 17).  The essential ingredients within the 13 
TeSR1 medium were the protein basic fibroblast growth factor (bFGF) and 14 
transforming growth factor beta (TGF) , Lithium Chloride, -aminobutyric acid 15 
(GABA) and pipecolic acid. Cell lines H1 and H9 were both shown to self-renew for 16 
more than 10 passages on a xeno-free growth substrate consisting of human collagen 17 
IV, fibronectin, laminin and vitronectin. The derivation of two new hPSC lines, 18 
WA15 and WA16, was also achieved using TeSR1. However, WA15 became trisomic 19 
(three chromosomes as opposed to two) for chromosome 12 between 4 and 7 months 20 
in culture. A variant of the TeSR1 culture cocktail has been commercialized as 21 
mTeSR1, employing BSA and zebrafish bFGF, as a cheaper alternative to the xeno-22 
free culture medium. To further aid hPSC culture, supplements such as Rho-23 
associated kinase (ROCK) inhibitors have been employed to reduce dissociation-24 
induced cell apoptosis when working in defined medium26. However the impact of 25 
these inhibitors and their long-term effects on hPSCs are yet to be understood.  26 
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To improve hPSC culture methodology, high-throughput screening has been used to 1 
discover small molecules that improve hPSC survival and self-renewal. In 2010, a 2 
high-throughput chemical screen of 50,000 synthetic compounds that identified small 3 
molecules added to the culture media promoted hPSC survival after trypsin 4 
dissociation from a Matrigel substrate27. Thiazovivin (Tzv) and Pyrintegrin (Ptn) were 5 
both found to dramatically increase cell survival versus DMSO controls. High-6 
throughput screening of small molecules can rapidly identify essential ingredients 7 
within current culture media employed in hPSC culture, and be used to reduce the 8 
number of components within the hPSC culture system (Box 1; refs. 26–40). 9 
Furthermore, this screening approach can identify novel culture medium supplements 10 
to aid the survival and self-renewal of hPSCs in defined culture conditions. 11 
 12 
Box 1. Challenges in hPSC culture for stem cell biologists. 13 
Improving current culture systems for the expansion of hPSCs is essential before the 14 
full potential of hPSCs can be realized in clinical applications. To be routinely used, 15 
hPSCs would ideally be produced in a good manufacturing practice (GMP) grade 16 
culture system.  Currently, the definition of GMP in terms of hPSC technologies is 17 
still being established as undefined culture systems have entered phase 1 clinical 18 
trials. However, with the advent of defined substrates, regulators will inevitably 19 
require all the components of a GMP grade culture system to be xeno-free, fully 20 
defined, and amenable to large scale production, ideally in an automated process. This 21 
presents a major challenge in hPSC culture to stem cell biologists. GMP-grade hPSCs 22 
would have to be fully characterized following large scale production to ensure that 23 
normal karyotype, proliferation rate, pluripotency-associated marker profile and 24 
differentiation potential had been maintained following long term culture within the 25 
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system. The success of hPSC culture systems to produce such cells depends on 1 
controlling the dynamic interactions that occur between the hPSCs, the medium 2 
components and the growth substrate. As such, there has been much recent 3 
investigation into the development of defined synthetic substrates, as well as defined 4 
synthetic medium supplements that improve hPSC culture systems. 5 
Traditional medium supplements most commonly consist of biological molecules 6 
such as growth factors and serum proteins to aid successful hPSC culture. Recently, 7 
small molecule chemistries have been shown to influence hPSC behaviour in culture, 8 
including differentiation activity and reprogramming potential. Importantly, there 9 
have been numerous molecules reported to promote the survival and self-renewal of 10 
hPSCs when added to the culture medium (Table B1).  11 
These molecules can manipulate hPSC activities by the activation or inhibition of key 12 
molecules within signalling pathways including MEK (PD0325901 and PD98059)28-13 
29, ROCK (Y27632, Thiazovivin, HA-1077, and Pinacidil)26-27,30-31, FGF (SU5402 14 
and PD173074)32, ERK (SC1)33, and GSK3 (Bio, CHIR99021, and 15 
Bisindolylmaleimide 1i)28,34-35. As such, small molecule chemistries hold great 16 
potential as medium supplements in the development of fully defined and cost-17 
effective hPSC culture conditions that are amenable to GMP scale-up. 18 
Table B1. Small molecule supplements for hPSC survival and self-renewal. 19 
BIO (6-bromoindirubin-3-oxime)34 20 
Bisindolylmaleimide 1i35  21 
CHIR99021 (Calbiochem)28  22 
Geldanamycin36  23 
HA-1077 (Fasudil)30  24 
ID-837 25 
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PD032590128  1 
PD17307432  2 
PD9805929  3 
Pinacidil31 4 
Pyrintegrin27 5 
Retinol38 6 
SC1 (Pluripotin)33 7 
SU540232  8 
SU665640  9 
Thiazovivin27  10 
U012639  11 
ROCK Y-2763226  12 
 13 
 14 
Protein-based growth substrates 15 
 16 
Following the identification of mixtures of ECM proteins as adsorbates required for 17 
hPSC growth and self-renewal, effort was focused on identifying which proteins are 18 
most effective with specific media. The laminins (LN)-111, -332 and -511 were 19 
identified as successful substrates for hPSC culture when used in combination with 20 
MEF-CM41. The hPSC lines KhES-1 and KhES-3 were found to express pluripotency 21 
markers after 10 passages, and showed equal growth on LN-332 compared to 22 
Matrigel at 72 hours.  The utility of these substrates was attributed to their high 23 
affinity for the α6β1 integrin expressed on hPSCs. More recently, analogues of these 24 
substrates employing laminin E8 fragments (functionally minimal forms of laminin 25 
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that can bind the α6β1 integrin) have been shown to support hPSC self-renewal in 1 
defined xeno-free medium for 10 passages42. Laminin-332E8 and -511E8 surfaces 2 
were able to support the self-renewal of H9, HES3, KhES-1 (hESC lines) and 3 
iPS(IMR90)-1, 253G1 (iPSC lines) in mTeSR1 and StemPro medium. Furthermore, 4 
all cell lines displayed normal karyotype at passage 10. These simplified laminin 5 
substrates were demonstrated to be successful for hPSC expansion at larger scale, 6 
such as T-75 tissue culture polystyrene flasks.  7 
A similar study demonstrated the long-term growth of hPSCs on LN-511 coated 8 
plates for 20 passages over 4 months in chemically defined O3 medium and xeno-free 9 
H3 medium (both variants of TeSR1)43. Furthermore, cells were able to attach and 10 
migrate over/across the LN-511 coating, creating continuous cell monolayers due to 11 
their affinity for the α6β1 integrin. This phenomenon was thought to have aided the 12 
long-term self-renewal of the hPSCs. However, passaging the cells required physical 13 
removal of the cells from the LN-511 coated plates, resulting in cell clumps rather 14 
than single-cell suspensions. Furthermore, this method of passaging is incompatible 15 
with automation which limits the scalability of this culture system.  16 
 17 
Peptide-based growth substrates 18 
 19 
Following the use of substrates coated with protein and protein fragments to promote 20 
hPSC adhesion, substrates presenting specific peptide sequences have been developed 21 
to identify and utilize specific interactions at the cell/material interface that mediate 22 
stem cell behaviour. Microarrays of spotted laminin fragments were presented via 23 
self-assembled monolayers (SAMs) by spotting 18 thiol functionalized peptides onto 24 
gold slides to rapidly identify cell-binding potential44. H1 and H9 cells that attached 25 
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and proliferated after 6 days on certain laminin sequences displayed pluripotency 1 
markers at similar levels to Matrigel controls. However, scale up from micro array 2 
spots, and expansion and long-term self-renewal on these surfaces, was not 3 
demonstrated. Furthermore, the MEF-CM used to culture the hPSCs makes this a 4 
complex, xenogenic and ill-defined system, as it contains many proteins and other 5 
biomolecules in the medium that adsorb to the surface. 6 
 7 
Carboxylate-containing acrylate monomers immobilized on plasma-treated 8 
polystyrene plates, and subsequently conjugated to various RGD-containing short 9 
peptide sequences through the N-terminus, have been used to generate peptide-10 
acrylate surfaces (PAS)45. Of the six peptides employed, only two (bone sialoprotein 11 
(BSP) and VN-derived peptide) supported hPSC attachment, suggesting that RGD 12 
alone is not a sufficient binding motif. BSP- and VN-PAS were able to demonstrate 13 
long-term self-renewal (more than 10 passages), and were scalable to 75 cm2 flasks. 14 
High surface density of the supportive peptide was required to achieve growth rates 15 
similar to Matrigel, with concentrations of BSP ranging from 0.75–1 mM, yielding 6–16 
9 pmol/mm2 in peptide density. VN-PAS-coated flasks seeded with hPSCs and 17 
cultured for 4 days in defined medium showed uniform cell distributions, and typical 18 
morphology, and expressed the pluripotency marker OCT4. This substrate has been 19 
developed commercially and marketed as Synthemax13 (Table 2). However, because 20 
of the biological components used in this substrate, it is expensive (about $100 for 21 
each T75 flask) compared to the widely used laboratory growth substrate Matrigel 22 
(approximately $15 per T75 flask). Another example of a growth substrate that has 23 
been commercially developed is StemAdhere14. This growth substrate employs a 24 
fusion protein of the IgG Fc domain and E-cadherin (a Ca2+ dependent cell–cell 25 
 13 
 
adhesion molecule), which is coated onto polystyrene plates. StemAdhere was able to 1 
support long-term culture of H9 cells (90 passages) in mTeSR1 medium. Similarly to 2 
Synthemax, the recombinant nature of StemAdhere increases the expense of using 3 
these substrates significantly. The cost of the culture ware alone to produce 1 billion 4 
hPSCs (an approximation for a single patient intervention) are estimated to be about 5 
$10,000 and $15,000 for Synthemax and StemAdhere, respectively (Table 3). This is 6 
likely to be prohibitive for cell expansion in clinical and biomedical uses, and is 7 
considerably greater than that of using Matrigel, which is estimated to be about 8 
$1,500 (excluding the cost of cells and media) to produce 1 billion hPSCs. Phase 1 9 
trials have been passed by regulators using Matrigel as an expansion substrate, but the 10 
exact meaning of good manufacturing practice (GMP) is still evolving for hPSC 11 
technologies; as more defined systems become available, they are likely to be 12 
required. 13 
  14 
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Table 3. Recent developments in defined growth substrates for adherent hPSC culture.  1 
Growth  Culture      hPSC Passages  Passaging Pluripotency   Karyotyping    Cost/    Cost per   Substrate  2 
substrate  medium      line      method criteria            Scalabilitya          109 hPSCs   Characterization 3 
Biological 4 
Substrates 5 
Synthemax13  X-VIVO 10,      H1, H7. 10   collagenase OCT4, SSEA-4,      data not shown              $380/10mg,  ~$10,000b    Fluorescence 6 
(peptide-polymer  80ng/mL hrbFGF   teratomas                $80 / 6 well plate    7 
conjugate) 0.5ng/mL hrTGF-β                   $100 / T75 8 
                     $295 / T225  9 
                      *** 10 
StemAdhere14 mTeSR1      H1, H9, iPSC >60   accutase OCT3/4, ZFP42,       H9 normal               $100 / kit ~$15,000c    Fluorescence 11 
(recombinant     SSEA4, NANOG                $22 / 0.5mg 12 
E-Cadherin)                      ** 13 
 14 
Peptide-SAM49 mTeSR1 + ROCK    H1, H7, H9, 6 (H1, H7),   manually OCT4, SSEA-1/3/4,   Trisomy on               Expensive >$15,000d    Fluorescence 15 
(synthetic       H13, H14, 19 (H9), 14 (H13) SOX2, TRA-1-60,      chromosome                *     16 
peptide)       IMR-90-1 17 (H14),  TRA-1-81,         17 (H14), other 17 
   7 (IMR-90-1)  teratomas        lines normal 18 
Polymeric 19 
Substrates 20 
PMVE-alt-MA46 StemPro + suppl.      HUES1, 5   accutase OCT4, NANOG        HUES1 and               Inexpensive ~$1,100e     FT-IR 21 
 with DMEM-F12      HUES9   teratomas        HUES9 normal            *** 22 
 (2% (v/v) BSA)      iPSC 23 
 24 
PMEDSAH47 StemPro suppl.      BG01, H9 3 (BG01)   mechanical OCT3/4, SOX2        BG01 and                Inexpensive ~$1,100e     WCA, XPS, FT-IR 25 
 with DMEM-F12       10 (H9)  + EB (BG01)        H9 normal                ***         elastic modulus 26 
 + L-glutamine,    OCT3/4, SOX2, 27 
 15mM HEPES    SSEA-4, TRA-1-60,  28 
TRA-1-81, 29 
teratomas (H9) 30 
 31 
APMAAm48 mTeSR1       H1, H9 >20  collagenase OCT4, SSEA-4           H1 and H9               Inexpensive ~$1,100e     WCA, XPS 32 
     + EB         normal (p10)               ***  33 
 34 
15A-30%53 mTeSR1       BG01, 5  collagenase OCT4, SSEA-4,         BG01 and                 Inexpensive ~$1,100e     WCA, elastic modulus, 35 
 (pre-adsorption of      WIBR3   TRA-1-60, NANOG   WIBR3 normal            ***       surface roughness, 36 
 HSA to polymer)    teratomas         ToF-SIMS 37 
 38 
UV/Ozone mTeSR1 + ROCK     BG01, >10   collagenase OCT4, SSEA-4,         normal >p5 with        Inexpensive ~$1,000f     XPS, ToF-SIMS 39 
treated TCPS (pre-adsroption of     WIBR1    accutase SOX2, NANOG,         ROCK (abnormal       ***   40 
 hrVN, 20% HSA       WIBR3   teratomas         at p5 without ROCK 41 
 or 20% FBS to 42 
 polymer) 43 
 44 
HG2155 mTeSR1       RH1, H9 >20 (RH1)    thermally  OCT3/4, NANOG     deletions/duplications   Inexpensive ~$1,100e     XPS, rheology 45 
   9 (H9)    induced SOX2, SSEA-4,       on chromosomes 8, 9,    *** 46 
     TRA-1-60, EB,       13, 20 (p21) 47 
     teratomas 48 
      49 
a Scalability determined by the ability to synthesize the material in large quantities for 50 
hPSC production in a cost-effective and timely manner; b estimated using 100 x coated 51 
T75 flasks required to achieve 1 billion hPSCs; c  estimated by 150 kits required to 52 
coat a sufficient number of 6 well plates to achieve 1 billion hPSCs; d estimated to be 53 
at least as expensive as a similar recombinant protein-based substrate such as 54 
StemAdhere; e estimated by the cost of commercial monomers of about $0.5/g and 55 
50mg of dissolved polymer required to coat 350 T75 flasks; f estimated by the cost of 56 
350 T75 flasks. 57 
 58 
 59 
 60 
 61 
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Polymer-based growth substrates 1 
 2 
Systems that we classify as scalable are those which can be used to produce billions 3 
of cells in an economical and safe manner for many patients. A benchmark in the 4 
pharmaceutical industry to screen differentiated stem cells for drugs is to achieve a 5 
cost of less than $1 per well (in a 96 well plate). This is not currently achievable for 6 
pluripotent stem cell culture. The peptide–polymer-derived substrates mentioned 7 
previously are amenable to commercial development, but ideally the substrate should 8 
be fully synthetic using readily synthesized and cheap components. Polymers formed 9 
from readily synthesised monomers would be ideally suited to meet this challenge and 10 
emulate the success of treated polystyrene substrates used so widely for general cell 11 
culture. 12 
To this end, a number of groups have embarked on the search for polymeric substrates 13 
to maintain pluripotent stem cell expansion. Polymerization from surfaces has been 14 
used to prepare six acrylate-based surfaces via ozone-activation of tissue culture 15 
polystyrene (TCPS) and subsequent surface-initiated polymerization with a range of 16 
acrylate monomers47. One of these materials (poly [2-(methacryloyloxy)ethyl 17 
dimethyl-(3-sulfopropyl) ammonium hydroxide]; PMEDSAH), was able to support 18 
the long-term culture of hPSC in serum-free defined mTeSR1 medium (including 19 
protein supplement; Fig. 1d(iii)). H9 cells were supported through 10 passages using 20 
StemPro medium showed normal karyotype, and expressed levels of pluripotency 21 
markers that were similar to cells cultured on Matrigel. However, no scalability was 22 
demonstrated using this substrate material. Another example of reactions with 23 
polystyrene is a aminopropylmethacrylamide-based coating (Fig. 1d(iv)) grafted to 24 
TCPS dishes using a photoinitiated addition polymerization48. H1 and H9-hOCT-pGZ 25 
hPSC lines were cultured in mTeSR1 medium for 10 passages, maintained typical cell 26 
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morphology, and grew in colonies similar to Matrigel cultured cells. Bovine serum 1 
albumin (BSA) was proposed to play a crucial role in hPSC attachment achieved in 2 
the culture medium. Quartz crystal microbalance with dissipation (QCM-D) 3 
experiments were used to identify BSA adsorption to the growth substrate from the 4 
mTeSR1 medium.  5 
 6 
 7 
 8 
Figure 1 | The development of hPSC growth substrates. (a) Feeder layers of MEFs 9 
to support cell adhesion and to condition the culture medium with ECM proteins to 10 
facilitate hPSC self-renewal. (b) Surface coating with an undefined ECM protein-11 
containing mixture such as Matrigel. (c) Functional epitopes of ECM components 12 
immobilized to the surface to encourage hPSC attachment and self-renewal. (d) 13 
Polymeric growth substrates to provide an environment to adsorb essential ECM 14 
proteins from the culture medium: (i) UV/ozone-modified polystyrene, (ii) 15 
poly(methyl vinyl ether-alt-maleic anhydride), (iii) poly[2-(methacryloyloxy)ethyl 16 
dimethyl-(3-sulfopropyl)ammonium hydroxide] (PMEDSAH), (iv) 17 
aminopropylmethacrylamide (APMAAm), (v) polymer micro array of 18 
triacrylate/diacrylate copolymer (15A-30%) and (vi) 2-(acryloyloxyethyl) 19 
trimethylammonium chloride/2-(diethylamino)ethyl acrylate copolymer (HG21). 20 
 21 
 22 
(a) (b) (c) (d)
(i)
(ii)
(iii) (iv) (v) (vi)
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 1 
High-throughput materials discovery for stem cell culture 2 
 3 
The defined growth substrates for adherent hPSC culture surveyed above have 4 
limitations, and consequently the search for new materials for hPSC culture continues. 5 
As we lack mechanistic understanding of why cells respond to materials and media, 6 
high-throughput methodologies have been employed to screen as wide a 7 
combinatorial chemical space as possible for materials supporting the number 8 
expansion of pluripotent cells.  9 
Surface-modification strategies such as self-assembly have been used to present 10 
molecules capable of binding to cell-surface integrins with high spatial resolution44.  11 
Arrays of peptide-substituted alkanethiols have been prepared as self-assembled 12 
monolayers on gold surfaces49. The molecules screened included peptides containing 13 
RGD and glycosaminoglycan binding epitopes, the most successful of which being a 14 
heparin-binding peptide derived from vitronectin (VN) (GKKQRFRHRNRKG). This 15 
peptide was able to support long-term self-renewal of hPSCs at peptide densities of 16 
0.5–25% (% peptide-substituted alkane thiol in mixed SAM monolayer) when 17 
combined with ROCK inhibitor or cyclic RGD peptide. This peptide was used to 18 
functionalize glass and gold coated slides. Furthermore, biotinylated-19 
GKKQRFRHRNRKG was used to functionalize steptavidin-coated TCPS dishes in a 20 
facile manner to reduce the cost of employing this peptide. However, hPSC expansion 21 
was not demonstrated over large areas, for instance in a culture flask. 22 
Pre-synthesized polymer libraries have been printed as microarrays50, employing the 23 
concept of combinatorial polymer libraries first shown in 1997 (ref. 51). For high-24 
throughput materials discovery, this has the limitation that polymer synthesis is time 25 
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consuming, reducing the diversity of such arrays and slowing the follow up of leads 1 
generated using subsequent arrays. Ideally, the evolution from the initial screen to 2 
future generation arrays arises from hypotheses being formed from a first generation 3 
array that are subsequently tested in generations that evolve rapidly according to the 4 
results generated. In 2010, a polymer microarray consisting of 91 commercially 5 
available and pre-synthesized polymers was employed to screen for hPSC attachment 6 
in StemPro medium46. A broad range of polymer backbones and side-chain 7 
functionalities were screened, including styrenes, acrylates and acrylamides spotted 8 
onto acrylamide-coated glass slides.  Of the initial hits identified by high OCT4 and 9 
NANOG expression using fluorescence microscopy to identify pluripotency, one 10 
polymer (poly(methyl vinyl ether-alt-maleic anhydride); Fig. 1d(ii)) was able to 11 
support hPSC attachment and self-renewal for  more than 5 passages using StemPro 12 
medium. Scalable expansion of hPSCs on this polymeric substrate was not 13 
demonstrated beyond cell expansion on polymer-coated slides.  14 
On-slide synthesis of polymer microarrays, achieved in 2004 (ref. 52), allows rapid 15 
synthesis of acrylate polymers by combinatorial mixing of liquid monomers printed 16 
onto a hydrogel-coated slide prior to UV photoinitiated free-radical polymerization. A 17 
strength of polymer microarrays is the ability to rapidly assess cell response to a large 18 
polymer library coupled with surface analysis of the library on the array, to allow 19 
cell–material surface interactions to be investigated3. 20 
 21 
Subsequently, several groups have used polymer microarrays to screen surface 22 
chemistries for hPSC attachment in a variety of culture media46,52,54. In 2010, a 23 
number of generations of polymer microarray were screened, starting with a library of 24 
496 unique materials formed by mixing 16 acrylate  ‘major’ monomers with 6 ‘minor’ 25 
 19 
 
monomers that were then contact printed onto a poly(2-hydroxyethyl methacrylate) 1 
(pHEMA)-coated substrate and polymerized in-situ using UV irradiation53. Polymers 2 
with potential as supports for pluripotent stem cells were identified by their ability to 3 
support the clonal growth of BG01-OCT4-GFP+ cells from very low initial seeding 4 
densities over 7 days in MEF-CM (arrays pre-conditioned with FBS). High-content 5 
fluorescent microscopy was used to quantify cell response to the individual polymer 6 
spots using OCT4 GFP. High-throughput surface characterization of the microarray 7 
was used to quantify the materials chemistry and properties such as wettability and 8 
indentation elastic modulus, which were compared to cell performance to identify the 9 
controlling surface factors. Colony-formation efficiency, a measure of the number of 10 
colonies formed at day 7 from the initial low cell attachment on day 1, was used to 11 
quantify the performance of the hit substrates pre-adsorbed with ECM proteins. 12 
Human vitronectin pre-adsorbed surfaces gave the highest colony formation 13 
efficiency in mTESR1 medium, maintaining pluripotency for 10 passages over 8 14 
weeks on microarrays comprising the hit materials (monomer 9 and 15A); however, 15 
only medium-term passaging (more than 5 passages over 1 month) was reported on 16 
surfaces pre-incubated with human serum albumin (HSA), and scalability beyond 17 
microarray spots was not demonstrated for the hit materials (Fig. 1d (v)), although 18 
slides covered with the same polymer spots were used to obtain sufficient cell 19 
numbers for laser scanning cytometry.   20 
A subsequent study used UV-ozone modification of polystyrene which maintained 21 
pluripotency for more than 10 passages on surfaces conditioned with HSA or human 22 
Vn in mTESR1 medium54. This growth substrate represents an attractive, cost-23 
effective and simple route amenable to scale up, although Vn is still required as a pre-24 
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adsorption step for both approaches, which increases the cost of employing this 1 
culture system (Fig. 1d (i)). 2 
More recently, a microarray of 609 different thermoresponsive polymers produced by 3 
ink-jet printing 18 acrylate and acrylamide monomers with a crosslinker in various 4 
ratios was reported55. The best performing material, an acrylate copolymer consisting 5 
of trimethylammonium chloride and diethylamino side-groups (HG21), supported the 6 
long-term self-renewal of RH1 cells (hPSC line) in mTeSR1 medium (more than 20 7 
passages). Karyotype analysis of the RH1 cells at passage 21 found chromosomal 8 
abnormalities. This highlights the need for characterization of hPSCs at high passage 9 
number, as abnormalities can occur after several passages, which render the hPSCs 10 
unusable for clinical application. The thermoresponsive nature of the copolymer 11 
hydrogel permitted cellular detachment by reducing the culture-medium temperature 12 
to 15oC for 30 minutes. This step may be useful in automated stem-cell-expansion 13 
systems. Growth rates of RH1 cells on hydrogel-coated coverslips were significantly 14 
lower than Matrigel controls; RH1 cells took 8–10 days to reach 80% confluence on 15 
the hydrogel coating, as opposed 4–5 days on Matrigel in mTESR1 medium. Xeno-16 
free culture medium was not used, and scalability of this growth substrate was not 17 
demonstrated beyond coating of cover slips. The thermo switch of the gels was 18 
characterized by bulk rheology measurements of materials on cover slips. 19 
 20 
 21 
Mechanism of cell response to surface cues 22 
 23 
Efforts have been directed towards understanding the effect of materials on the 24 
regulation of stem cell behaviour by designing substrates with particular chemistries, 25 
 21 
 
compliances, topographies, or containing biologically relevant moieties49,56-57.  Cell-1 
adhesion molecules that govern cell–matrix and cell–cell interactions play a crucial 2 
role in the long-term maintenance and self-renewal of adhered hPSCs. The 3 
identification of cell-surface integrins that can engage with Matrigel (β1) and 4 
Vitronectin (αvβ3 and αvβ5) -coated substrates has enabled understanding of how 5 
hPSC pluripotency is maintained42,53,58-59. Cell–cell interactions mediated by 6 
cadherins and their role towards hPSC behaviour have been extensively studied over 7 
recent years (see ref. 60 for a recent review of this area). Specifically, substrates 8 
presenting E-cadherin have been commercialized as StemAdhere, and have proven to 9 
be useful for hPSC expansion14. 10 
Adsorption of individual proteins on polymeric substrates and the subsequent effect 11 
upon cellular performance have been well studied61,62. However, knowing which 12 
proteins adsorb from protein-containing media onto materials, and the conformation 13 
they adopt on adsorption to a synthetic surface, is an essential element in gaining an 14 
understanding of material performance in protein-containing culture conditions. Such 15 
knowledge will ultimately direct materials discovery towards improved substrates for 16 
hPSC culture. 17 
The topography and elastic modulus of synthetic substrates have been shown to 18 
influence the differentiation of stem cells63–65. These studies highlight the importance 19 
of physical, as well as chemical, properties in regulating self-renewal and 20 
differentiation in future culture systems used for large scale manufacture of hPSCs. 21 
Recently, the heparin-binding peptide GKKQRFRHRNRKG (see earlier discussion) 22 
was attached to hydrogel-based surfaces of various moduli to enable mechanical 23 
control of hPSC self-renewal67. Immobilization of the peptide on the hydrogel 24 
substrates was achieved by a chemoselective reaction between maleimide moieties 25 
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and the peptide terminated with a cysteine residue. Only stiff hydrogels (10 kPa) were 1 
able to maintain hPSC pluripotency, which was facilitated by the activation of the 2 
Yes-Associated Protein (YAP) and the transcriptional coactivator with PDZ-binding 3 
motif (TAZ). The hydrogel which exhibited a Young Modulus of 10 kPa, determined 4 
by force indentation measurements using AFM, was most effective at inducing 5 
YAP/TAZ nuclear localization. 6 
 7 
 8 
Modelling and Predicting Material Performance 9 
 10 
To support experimental materials discovery, computational methods capable of 11 
predicting the role of materials in encouraging cellular attachment have been 12 
explored68 (Fig. 2). An early example of this was demonstrated for fibroblasts by 13 
identifying polymer–cell-response relationships within a combinatorial library via 14 
pre-synthesized copolymer-coated glass coverslips69. Linear correlations were 15 
observed between fibroblast proliferation and polymer-surface hydrophobicity for a 16 
subset of the library of polymers. Thermal and physical properties of the polymer 17 
library such as glass transition temperature (Tg) and water contact angle (WCA) were 18 
predicted successfully using a molecular descriptor called the total flexibility index 19 
(the number of carbon atoms at modification points within the copolymer structure).  20 
More recently, human-embryoid-body cell adhesion to a library of polymers has been 21 
linked to molecular descriptors indicating that computational approaches may be used 22 
to guide the design of materials production for experimentation with stem cells (Fig. 23 
2)70. 24 
 23 
 
 1 
Figure 2 | High-throughput materials discovery. (a) Concept:  The small materials-2 
design space that can readily be accessed experimentally limits the discovery of new 3 
materials for hPSC culture. Directed materials discovery can be achieved through 4 
advanced modelling methods that enable structure-property relationships (SPRs) to be 5 
developed. This has the potential to allow access to a materials design space yet to be 6 
explored experimentally. (b) Workflow (i) High-throughput sample formats such as 7 
polymer microarrays can be screened for new growth substrates for hPSC culture to 8 
access a small proportion of the potential chemical space. (ii) High-throughput surface 9 
characterization can be employed in parallel to the biological assay. Correlation of the 10 
surface analytical data with cell performance using multivariate partial least-squares 11 
(PLS) regression links structure to function. Neural networks can identify molecular 12 
descriptors correlating with cell response. (iii) The predictive models have the 13 
potential to identify material chemistries that could not have been predicted from the 14 
experimental data alone. (iv) These advanced modelling techniques can be used to 15 
develop SPRs that can be used to explore a new materials-design space. This process 16 
can be performed in an iterative manner until an optimized lead candidate material 17 
has been found and scaled up to coated culture ware for hPSC expansion (v). 18 
 19 
(v)
(a) (b)
(i)
(ii)
(iii)
(iv)
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Surface chemical measurements can be used to determine the surface chemistries 1 
controlling cell attachment to materials, with the aid of statistical and machine-2 
learning methods employed to aid interpretation of large data sets.  For example, 15 3 
oxygen-containing plasma-deposited films were characterized using static secondary 4 
ion mass spectrometry (SIMS)71.  A correlation between the positive and negative 5 
secondary-ion spectra from the materials and endothelial cell growth was determined 6 
using multivariate partial least-squares (PLS) regression. The PLS model identified 7 
ions within the SIMS spectra that contributed towards high and low cell attachment.  8 
Using a development of this approach, a combination of high-throughput surface 9 
characterization (surface mass spectral data) and multivariate analysis (MVA) was 10 
employed to predict the wettability of 576 polymers in a combinatorial microarray 11 
library72-73. A statistically valid PLS model between WCA measurements and spectra 12 
obtained using time-of-flight secondary ion mass spectrometry (ToF-SIMS) was 13 
obtained. This study demonstrated the utility of MVA techniques such as PLS to 14 
model large datasets containing a large number of variables such as ToF-SIMS 15 
spectra (each with hundreds of secondary ions) of a polymer microarray (containing 16 
hundreds of materials). Another study employed PLS regression to explore the 17 
relationship between surface chemistry of a combinatorial polymer microarray and the 18 
colony-formation frequency of hPSCs53. Good agreement between the measured 19 
colony-formation frequency and that predicted from the ToF-SIMS spectra from the 20 
material surfaces was found, highlighting the importance of material surface 21 
chemistry in controlling stem cell response. The approach also helped identify the 22 
controlling surface functionalities, to allow efficient materials discovery in which 23 
improvements from one micro array generation to the next are achieved to obtain the 24 
best performing combination of materials from the library of monomers available.  25 
 25 
 
The best performing polymers were pre-adsorbed with vitronectin before cell seeding. 1 
To investigate the role of this step, ToF-SIMS of these protein-conditioned polymer 2 
surfaces was used to analyze the chemistry of this surface. Strong correlations 3 
between cell attachment and characteristic protein secondary ions were identified, 4 
indicating the synergy existing between the material’s surface chemistry and the 5 
identity and amount of adsorbed proteins to enable colony-formation.  It is known 6 
from blocking experiments that the role of protein adsorption to polymeric growth 7 
substrates is pivotal to facilitate hPSC attachment and self-renewal via engagement 8 
with cell-surface integrins53. Understanding which proteins adsorb from complex-9 
protein-containing media to materials and their conformation is an essential 10 
component in interpreting material performance in protein-containing culture 11 
conditions, and will ultimately lead materials discovery towards better substrates for 12 
hPSC culture (Box 2). At present, however, unequivocal identification of protein 13 
identity and conformation from complex-protein-containing media is not possible. 14 
 15 
Box 2. Challenges in hPSC culture for material scientists. 16 
 17 
The move towards defined synthetic growth substrates for hPSC culture has been 18 
approached in a concerted manner and primarily driven by biologists aiming to 19 
achieve greater reproducibility during cell culture and remove xenogenic components. 20 
Materials scientists play an important role in meeting challenges posed by biologists 21 
via the design of scalable growth substrates capable of achieving high expansion rates 22 
of hPSCs whilst maintaining full pluripotency potential and a normal karyotype. 23 
A major challenge in material design is the development of a fully synthetic growth 24 
substrate that can adsorb essential proteins in the desired conformation from the 25 
culture medium to facilitate hPSC adhesion and expansion. The mechanism of hPSC 26 
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adhesion to biologically inspired growth substrates that display surface moieties such 1 
as RGD-containing peptides is well understood. However, there is gap in knowledge 2 
of how biomolecules adsorb to synthetic substrates which is limiting the rational 3 
design of improved synthetic growth substrates.  4 
One materials design approach towards functional synthetic growth substrates is to 5 
develop synthetic mimics of biological motifs known to be beneficial for hPSC 6 
adhesion eg. employing sulfonated synthetic polymers to mimic the functional 7 
characteristics of heparin47. This hypothesis-driven approach has led to the 8 
development of polymer-based growth substrates that can achieve hPSC expansion in 9 
defined media47-48, 53,55.  10 
Another design route for synthetic growth substrates is a combination of high-11 
throughput material and computational screening. It is often not appreciated how vast 12 
the possible ‘space’ of materials that could be synthesized is, and that it is not possible 13 
to explore even a tiny fraction of this by experiments. The vast design space of 14 
synthetic biomaterials presents many opportunities to discover better synthetic growth 15 
substrates. To meet this challenge and explore the chemical combinatorial design 16 
space more effectively; computational methods will be needed to complement 17 
experimentally derived hypotheses and better inform materials discovery screening. 18 
Computational modelling can contribute in several ways. Use of design of 19 
experiments (DoE) methods allows the number of experiments that are required to 20 
cover a given design space to be minimized74.  Computational models of the data 21 
from these experiments allow the properties of all materials within the design space to 22 
be predicted.  23 
If large-scale high throughput methods can be developed that capture sufficient 24 
molecular diversity on the materials, these models are capable of wide extrapolation 25 
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into materials space. Finally, evolutionary methods are beginning to be applied to 1 
materials design and discovery. They allow initial sets of promising materials to be 2 
evolved towards a desired materials property ‘fitness function’ in an experimentally 3 
efficient way.  These methods are among the most efficient at exploring extremely 4 
large design spaces. (Figure 2). 5 
 6 
  7 
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Outlook 1 
The search for new materials for adherent hPSC culture has been greatly accelerated 2 
by the recent application of high-throughput sample-screening strategies such as 3 
polymer microarrays. Surface characterization, and correlative and predictive models, 4 
make this a powerful approach with which to search for new materials. Development 5 
of quantitative structure–property relationships (SPRs), by using the results from large 6 
experimental libraries linking polymer structure to hPSC performance on materials, 7 
are likely to broaden the chemical combinatorial space beyond what is currently 8 
explored to facilitate the search for better materials for hPSC culture. The materials-9 
discovery process can be further aided through a combination with high-throughput 10 
screening of synthetic soluble factors that can replace biologically derived ingredients 11 
within hPSC culture media and increase the scalability of such culture systems. 12 
 13 
High-throughput materials screening is moving towards the ability to carry out 14 
directed high-throughput materials discovery so as to allow exploration beyond the 15 
existing experimentally investigated chemical space, and towards utilizing 16 
experimentally determined surface structure-property relationships (sSPRs) and 17 
computationally determined molecular descriptors. To enable these methods to evolve 18 
beyond the constraints of the current experimentally accessible chemical space will 19 
represent a step change in materials-discovery capabilities. Recently, molecular 20 
descriptors have been used to predict the response of stem cell attachment and to 21 
generate sSPRs in silico without the need for experimentally determined polymer 22 
characteristics70. Although the ‘reverse SPR’ problem (backing out a polymer 23 
structure from an SPR model) has been challenging in the past, developments in 24 
mathematics have recently provided practical methods for designing polymers with 25 
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optimal properties from SPRs and molecular descriptors75. Success in this endeavour 1 
would open up the full range of materials to computational examination so as to direct 2 
synthesis efforts to potentially fruitful areas for experimental exploration. We 3 
anticipate that these and the other material-discovery approaches covered in this 4 
review will provide the materials necessary for the stem cell factories of the future. 5 
 6 
Human pluripotent stem cells have presented possibilities in a wide variety of 7 
applications, such as regenerative medicine and pharmaceutical drug screening. In the 8 
future, stem cell factories will be required to produce the large numbers of hPSCs 9 
needed (in the billions) to meet the demands of regenerative-medicine interventions 10 
currently in clinical trials. The long-term expansion and self-renewal of hPSCs in 11 
xeno- and defined conditions is a prerequisite to achieving this. Xeno- and feeder-free 12 
E8 medium has now been commercialized21, and E6 — a medium used to reprogram 13 
somatic cells to hiPSCs prior to expansion in E8 — is currently under development.  14 
For adherent hPSC culture this will also need to be supported by chemically defined 15 
substrates that offer high growth rates in a reproducible manner. Suspension hPSC 16 
culture has been shown as a promising alternative to adherent hPSC culture. However, 17 
both refinement of the culture media components and improved growth rates versus 18 
adherent systems will need to be demonstrated before suspension culture can be 19 
considered as a viable alternative.  20 
 21 
The most recently developed defined substrates are polymers and peptides that are 22 
applicable to a xeno- and serum-free environment, but few are able to support the 23 
expansion of hPSCs at levels similar to that of the current gold-standard (but 24 
undefined) growth substrates, such as Matrigel. A number of novel polymers show 25 
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promise; still, they largely require protein pre-adsorption, or display significant 1 
limitations in industrial scale up (mainly cost). What the make-up and functionality 2 
will be of the future systems required to address these challenges is still unknown. 3 
However, several groups are taking clues from established large scale industry. For 4 
example, manufacturing of semiconductors uses fully automated closed robotic 5 
systems to couple high-throughput production and quality control parameters in the 6 
absence of human intervention. Combining synthetic materials able to support 7 
pluripotent stem cell expansion with such high throughput processing methods will 8 
enable the stem cell factories of the future in which large numbers of culture vessels 9 
will be used to expand cell numbers, e.g. slimline flasks using microfluidics to feed 10 
and quantify pluripotency status of adherent cells in fully automated, closed loop 11 
systems. For this area to develop further, the concurrent development of pluripotency-12 
compatible, next generation substrates will be essential for economically-viable hPSC 13 
manufacture. Substrates will likely include proprietary low cost 2D polymers, 14 
identified by high-throughput strategies, as well as 3D configurations that allow 15 
switching between induction of pluripotency and differentiation76. 16 
 17 
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